Signaling pathways engaged by NK cell receptors: Double concerto for activating receptors, inhibitory receptors and NK cells

Seminars in Immunology

Volumn 12, Issue 2, 2000, Pages 139-147

  Tomasello, Elena ^a   Blery, Mathieu ^a   Vely, Eric ^a   Vivier, Eric ^b  

^a INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^b INSERM   (France)

Author keywords

ITAM; ITIM; Kinases; Phosphatases

Indexed keywords

B LYMPHOCYTE ANTIGEN; CELL RECEPTOR; CELL SURFACE RECEPTOR; DISULFIDE; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE RECEPTOR;

ANTIGEN SPECIFICITY; CELL ACTIVATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VIRUS INFECTION;

EID: 0034038918     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2000.0216     Document Type: Article

References (84)

1. Adv Immunol. 47:1989;187-376.
2. Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L. Receptors for HLA-class-I molecules in human natural killer cells. Annu Rev Immunol. 14:1996;619-648.
3. Ann Rev Immunol. 16:1997;359-393.
4. Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 17:1999;189-220.
5. Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 187:1998;2065-2072.
6. Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, Parolini S, Moretta L Moretta A, Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 189:1999;787-796.
7. Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L, Bi assoni R, Moretta A. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med. 188:1998;953-960.
8. Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol. 29:1999;1656-1666.
9. Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, Marcenaro E, Accame L, Malaspina A, Biassoni R, Bottino C, Moretta L, Moretta A. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 190:1999;1505-1516.
10. Bauer S, Groh V, Wu J, Steinle A, Phillips J H, Lanier L L, Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285: 1999;727-729.
11. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391: 1998;795-799.
12. Valés-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:1999;4250-4260.
13. Ryan JC, Niemi EC, Nakamura MC, Seaman WE. NKR-P1A is a target-s pecific receptor that activates natural killer cell cytotoxicity. J Exp Med. 181:1995;1911.
14. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol. 162:1999;6981-6985.
15. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci USA. 96:1999;5640-5644.
16. Medzhitov R, Janeway CA. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997;295-298.
17. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
18. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E. Killer-cell activatory receptors for MHC Class I molecules are included in a multimeric complex expressed by human killer cells. J Immunol. 158:1997;5083-5086.
19. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703-707.
20. Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP-12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693-701.
21. Tomasello E, Olcese L, Vely F, Geourgeon C, Blery M, Moqrich A, Gautheret D, Djabali M, Mattei MG, Vivier E. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem. 273:1998;34115-34119.
22. Arase N, Arase H, Park SY, Ohno H, Ra C, Saito T. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1(+) T cells. J Exp Med. 186:1997;1957-1963.
23. Bruyns E, Marie-Cardine A, Kirchgessner H, Sagolla K, Shevchenko A, Mann M, Autschbach F, Bensussan A, Meuer S, Schraven B. T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-ζ complex, recruits intracellular signaling proteins to the plasma membrane. J Exp Med. 188:1998;561-575.
24. Wofsy C, Torigoe C, Kent UM, Metzger H, Goldstein B. Exploiting the difference between intrinsic and extrinsic kinases: implications for regulation of signaling by immunoreceptors. J Immunol. 159:1997;5984-5992.
25. Ting AT, Dick CJ, Schoon RA, Karnitz LM, Abraham RT, Leibson PJ. Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells. J Biol Chem. 270:1995;16415-16421.
26. Van Oers NS, Lowin-Kropf B, Finlay D, Connolly K, Weiss A. αβ T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity. 5:1996;429-436.
27. Chu DH, Morita CT, Weiss A. The Syk family of protein tyrosine kinase in T-cell activation and development. Immunol Rev. 165:1998;167-180.
28. Brumbaugh KM, Binstadt BA, Billadeau DD, Schoon RA, Dick CJ, Ten RM, Leibson PJ. Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med. 186:1997;1965-1974.
29. Negishi I, Motoyama N, Nakayama K, Senju S, Hatakeyama S, Zhang Q, Chan AC, Loh DY. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature. 376:1995;435-438.
30. Colucci F, Turner M, Schweighoffer E, Guy-Grand D, Di Bartolo V, Salcedo M, Tybulewicz VL, Di Santo JP. Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation. J Immunol. 163:1999;1769-1774.
31. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 92:1998;83-92.
32. Peterson EJ, Clements JL, Fang N, Koretzky GA. Adaptor proteins in lymphocyte antigen-receptor signaling. Curr Opin Immunol. 10:1998;337-344.
33. Marie-Cardine A, Kirchgessner H, Bruyns E, Shevchenko A, Mann M, Autschbach F, Ratnofsky S, Meuer S, Schraven B. SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T cell activation. J Exp Med. 189:1999;1181-1194.
34. da Silva AJ, Li Z, de Vera C, Canto E, Findell P, Rudd CE. Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc Natl Acad Sci USA. 94:1997;7493-7498.
35. Zhang W, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, Trible RP, Grinberg A, Tsay HC, Jacobs HM, Kessler CM, Long EO, Love PE, Samelson LE. Essential role of LAT in T cell development. Immunity. 10:1999;323-332.
36. Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Irvin BJ, Zhang W, Samelson LE, Abraham RT, Leibson PJ. Cutting edge: a role for the adaptor protein LAT in human NK cellmediated cytotoxicity. J Immunol. 162:1999;2453-2456.
37. Yablonski D, Kuhne MR, Kadlecek T, Weiss A. Uncoupling of nonreceptor tyrosine kinases from PLC - 1 in an SLP-76-deficient T cell. Science. 281:1998;413-416.
38. Peterson EJ, Clements JL, Ballas ZK, Koretzky GA. NK cytokine secretion and cytotoxicity occur independently of the SLP-76 adaptor protein. Eur J Immunol. 29:1999;2223-2232.
39. Galandrini R, Palmieri G, Piccoli M, Frati L, Santoni A. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells. J Exp Med. 183:1996;179-186.
40. Billadeau DD, Brumbaugh KM, Dick CJ, Schoon RA, Bustelo XR, Leibson PJ. The vav-rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J Exp Med. 188:1998;549-559.
41. Höglund P, Sundback J, Olsson-Alheim MY, Johansson M, Salcedo M, Öhlen C, Ljunggren HG, Sentman CL, Kärre K. Host MHC class I gene control of NK-cell specificity on the mouse. Immunol Rev. 155:1997;11-28.
42. Garrido F, Ruiz-Cabello F, Cabrera T, Pérez-Villar JJ, Lòpez-Botet M, Duggan-Keen M, Stern PL. Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today. 18:1997;89-95.
43. Tay CH, Szomolanyi-Tsuda E, Welsh RM. Control of infections by NK cells. Curr Top Microbiol Immunol. 230:1998;193-220.
44. Moretta A, Moretta L. HLA class I specific inhibitory receptors. Curr Opin Immunol. 9:1997;694-701.
45. Lang S, Vujanovic NL, Wollenberg B, Whiteside TL. Absence of B7.1-CD28/CTLA-4-mediated costimulation in human NK cells. Eur J Immunol. 28:1998;780-786.
46. Long EO, Wagtmann N. Natural killer cell receptors. Curr Opin Immunol. 9:1997;344-350.
47. Olcese L, Lang P, Vély F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol. 156:1996;4531-4534.
48. Burshtyn DN, Long EO. Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell Biol. 7:1997;473-479.
49. Vivier E, Daëron M. Immunoreceptor tyrosine-based inhibition motifs (ITIMs). Immunol Today. 18:1997;286-291.
50. Binstadt BA, Brumbaugh KM, Leibson PJ. Signal transduction by human NK cell MHC-recognizing receptors. Immunol Rev. 155:1997;197-203.
51. Cambier JC. Inhibitory receptors abound? Proc Natl Acad Sci USA. 94: 1997;5993-5995.
52. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 17:1999;875-904.
53. Bolland S, Ravetch JV. Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol. 72:1999;149-177.
54. Daëron M, Vivier E. Biology of immunoreceptor tyrosine-based inhibition motif bearing molecules. Curr Top Microbiol Immunol. 244:1999;1-12.
55. lckkinase. Eur J Immunol. 24:1994;2527-2534.
56. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J-P, Long EO. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 4:1996;77-85.
57. Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet J-P, Abraham RT, Leibson PJ. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity. 5:1996;629-638.
58. Leibson PJ. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity. 6:1997;655-661.
59. Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV. Del etion of SHIP or SHP-1 reveals two distincts pathways for inhibitory signaling. Cell. 90:1997;293-301.
60. Lorenz U, Ravichandran KS, Burakoff SJ, Neel BG. Lack of SHPTP1 r esults in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc Natl Acad Sci USA. 93:1996;9624-9629.
61. Pani G, Fisher K-D, Mlinaric-Rascan I, Siminovitch KA. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J Exp Med. 184:1996;839-852.
62. Valiante NM, Phillips JH, Lanier LL, Parham P. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-γ signalling complex in human NK cells. J Exp Med. 184:1996;2243-2250.
63. Binstadt BA, Billadeau DD, Jevremovi-cacute D, Williams BL, Fang N, Y1 T, Koretzky GA, Abraham RT, Leibson PJ. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J Biol Chem. 273:1998;27518-27523.
64. Plas DR, Johnson R, Pingel JT, Matthews RJ, Dalton M, Roy G, Chan AC, Thomas ML. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science. 272:1996;1173-1176.
65. Dustin LB, Plas DR, Wong j, Hu YT, Soto C, Chan AC, Thomas ML. E xpression of dominant-negative Src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation. J Immunol. 162:1999;2717-2724.
66. Huyer G, Alexander DR. Immune signalling: SHP-2 docks at multiple ports. Curr Biol. 9:1999.
67. Qu CK, Yu WM, Azzarelli B, Feng GS. Genetic evidence that shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals. Proc Natl Acad Sci USA. 96:1999;8528-8533.
68. Biassoni R, Pessino A, Malaspina A, Cantoni C, Bottino C, Sivori S, Moretta L, Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol. 27:1997;3095-3099.
69. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol. 161:1998;571-577.
70. Bléry M, Delon J, Trautmann A, Cambiaggi A, Olcese L, Biassoni R, Moretta L, Chavrier P, Moretta A, Daeron M, Vivier E. Reconstituted killer-cell inhibitory receptors for MHC Class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J Biol Chem. 272:1997;8989-8996.
71. Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse: a molecular machine controlling T cell activation. Science. 285:1999;221-227.
72. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
73. Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, Chauvin JP, Pierres M, He HT. Engagement of T celi receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 17:1998;5334-5348.
74. Xavier R, Brennan T, Li Q, McCommack C, Seed B. Membrane compart mentation is required for efficient T cell activation. Immunity. 8:1998;723-732.
75. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:1999;680-682.
76. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080.
77. Fanning AS, Anderson JM. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest. 103:1999;767-772.
78. Dustin ML, Olszowy MW, Holdorf AD, Li J, Browley S, Desai N, Widder P, Rosenberger F, van der Merwe A, Allen P, Shaw A. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell. 94:1998;667-677.
79. Timms JF, Swanson KD, Marie-Cardine A, Raab M, Rudd CE, Schraven B, Neel BG. SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages. Curr Biol. 9:1999;927-930.
80. Xu R, Pecht I. The mast cell function-associated antigen, a new member of the ITIM family. Curr Top Microbiol Immunol. 244:1999;159-168.
81. Falco M, Biassoni R, Bottino C, Vitale M, Sivori S, Augugliaro R, Moretta L, Moretta A. Identification and molecular cloning of p75/AIRM1, a novel member of the sieloadhesion family that functions as an inhibitory receptor in human natural killer cells. J Exp Med. 190:1999;793-802.
82. Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, Castriconi R, Vitale M, Pende D, Sivori S, Millo R, Biassoni R, Moretta L, Moretta A. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol. 29:1999;3148-3159.
83. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, van Schai k S, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, de Vries JE, Aversa G, Ter horst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:1998;462-469.
84. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. Human 2B4, an activating NK cell receptor, recruits the protein tyrosin e phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol. 162:1999;6981-6985.